Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam periradicular injections for low back pain
NCT02706054Phase 3Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- May 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of meloxicam in low back pain (LBP) (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Numeric Rating Scale Pain Score at 90 days. Started May 2012; status: completed.
02
Drugs
meloxicam
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT02706054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706054.